Challenges and opportunities in protecting IP in a deep tech startup
In this article for The Patent Lawyer Magazine, Partners Andrew White and Anna Gregson discuss the importance of protecting IP as an asset, even years before commercial use, in one of the largest… read more…
EPO fee increases from 1 April 2022: What you need to know
The European Patent Office (EPO) has announced it will be increasing official fees by approximately 25% from 1 April 2022 – two years since its last fee increase in April 2020 Full details of the… read more…
Key changes from the Revised Guidelines for Search and Examination at the EPO
Update: 9 March 2022 Having reviewed the final 2022 version which is now in force, there are no substantive changes compared to the preview, which the article is based on With that in mind,… read more…
Mathys & Squire Partners recognised in IAM Strategy 300 Global Leaders 2022
Mathys & Squire Partners Anna Gregson, Dani Kramer and Martin MacLean have been featured in the 2022 edition of IAM Strategy 300 Global Leaders The guide highlights professionals whose… read more…
G1/22 and G2/22: Board of Appeal refers questions on formal priority entitlement to the Enlarged Board of Appeal
In a development that could have a significant impact on how priority is assessed in Europe, EPO Board of Appeal 334 has just referred the following two questions to the Enlarged Board of Appeal… read more…
IP trends for 2022: Food innovation – from edible containers to potato milk and CBD-infused wine
As a result of the Covid-19 pandemic and spending increased time at home, many of us have taken a greater interest in what we eat, which has continued even beyond the banana bread craze of 2020… read more…
UPC newsflash: EPO announces two transitional measures to enable early uptake of Unitary Patent
The European Patent Office (EPO) has announced the introduction of transitional measures to encourage applicants towards an early uptake of the Unitary Patent effect Details can be found here, but… read more…
IP trends for 2022: Cleantech in the life sciences and chemistry sectors
The world’s attention remains, rightfully, focused on the goal of innovating its way to carbon neutrality – the pledges of the recent COP26 summit are just the most recent in decades of… read more…
IP trends for 2022: Personalised medicine and advanced therapy medicinal products
Personalised medicine has been a strong focus of pharmaceutical research and development (R&D) in recent years, and we expect this to continue in 2022 and beyond, with the global personalised… read more…
